Skip to main content
. 2012 Jul 24;11:86. doi: 10.1186/1475-2840-11-86

Table 1.

Patient’s characteristics with CMI or PAOD and their characteristics when classified as well-controlled (HbA1c ≤ 6.5) or poorly-controlled (HbA1c > 6.5) diabetic patients

 
  
  
 PAOD Subjects
  
  CMI Subjects PAOD Subjects DM2 with HbA1c ≤ 6.5 DM2 with HbA1c > 6.5
N (%)
 5 (25.0)
 15 (75.0)
 6 (40.0)
 9 (60.0)
Age (years)
 63.2 ± 13.0
 67.3 ± 14.2
 73.8 ± 11.8
 63.0 ± 14.6
Sex (Male/Female) (%)
 5/0
 12/3
 5 (83.3)/2 (16.7)
 7 (77.8)/2 (22.2)
Weight (Kg)
 75.9 ± 10.1
 68.7 ± 12.1
 63.5 ± 11.3
 72.1 ± 11.9
Waist circumference (cm)
 94.5 ± 3.5
 96.7 ± 8.7
 96.5 ± 12.7
 90.8 ± 19.2
BMI (kg/m2)
 27.9 ± 3.5
 25.3 ± 3.9
 24.6 ± 4.4
 25.7 ± 3.7
SBP/DBP (mmHg)
 133/74 ± 24/14
 150/76 ± 24/13
 141/78 ± 21/6
 155/75 ± 26/16
Glycemia (mg/dL)
 105.2 ± 8.3
 129.2 ± 48.1
 96.2 ± 31.1
 151.2 ± 32.6*
HbA1c (%)
 6.2 ± 0.3
 7.8 ± 1.8
 6.0 ± 0.4
 8.9 ± 1.3**
Creatinine (mg/dL)
 1.0 ± 0.3
 1.9 ± 0.9
 1.2 ± 0.7
 2.5 ± 1.7
Uric acid (mg/dL)
 5.4 ± 1.4
 4.5 ± 2.8
 3.6 ± 2.0
 5.3 ± 3.3
Total cholesterol (mg/dL)
 135.8 ± 37.9
 152.7 ± 55.6
 126.5 ± 67.0
 179.9 ± 61.1
LDL cholesterol (mg/dL)
 81.8 ± 15.5
 88.0 ± 28.12
 73.4 ± 21.7
 112.4 ± 52.2
HDL cholesterol (mg/dL)
 32.4 ± 12.0
 32.6 ± 13.8
 32.3 ± 18.9
 32.9 ± 9.0
Triglycerides (mg/dL)
 201.0 [106.0-302.0]
 122.0 [82.3-234.5]
 116.5 [74.8-131.5]
 210.5 [83.5-364.3]
GOT (U/l)
 27.2 ± 9.8
 34.23 ± 9.3
 40.8 ± 46.5
 28.6 ± 19.7
GPT(U/l)
 53.2 ± 30.0
 40.7 ±19.0
 42.5 ± 20.5
 39.1 ± 19.1
GGT (U/l)
 30.2 ± 9.8
 56.1 ± 7.1
 89.3 ± 40.7
 114.6 ± 132.8
Insulin (μUI/ml)
 13.5 ± 9.3
 11.8 ± 6.4
 10.5 ± 5.8
 12.6 ± 7.3
HOMA index
 5.9 ± 4.6
 4.1 ± 2.2
 2.8 ± 1.6
 5.3 ± 2.4
Hypertension (%)
 21.4
 73.3
 66.7
 77.8
Dyslipidemia (%)
 57.1
 85.7
 83.3
 87.5
Obesity (%)
 16.7
 33.3
 33.3
 33.3
Smoker (%) 33.3 13.3 11.1 22.2

Values are shown as mean ± SD (* p=0.02 vs well control; ** p=<0.0001 vs well control).